Ross Stores and Recursion Pharmaceuticals report insider share sales

Sarasin & Partners LLP cut its holding in Ross Stores, Inc. by 79.7% in the second quarter, selling 67,888 shares and ending the period with 17,285 shares valued at about $3.68 million.

Recursion Pharmaceuticals director Blake Borgeson sold 30,000 shares of the company on August 4 under a Rule 10b5‑1 plan, receiving an average price of $3.25 per share for a total of $97,500. After the transaction he retained roughly 6.19 million shares worth about $20.1 million.